Taysha gene therapies to participate in upcoming july investor healthcare conference

Dallas--(business wire)--taysha gene therapies, inc. (nasdaq: tsha), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing aav-based gene therapies for the treatment of monogenic diseases of the central nervous system (cns) in both rare and large patient populations, today announced its participation in a virtual fireside chat for the william blair biotech focus conference 2021. conference's details:   event: william blair biotech focus conference 2021
TSHA Ratings Summary
TSHA Quant Ranking